Phase 3 High cholesterol trials recruiting now

All High cholesterol trials, every phase

Other phases for High cholesterol

Phase 3 High cholesterol trials

• A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
  NCT07619131 · Phase: Phase 3 · Ages: 18 Years to 130 Years · Sex: All (male and female) · 152 locations
• A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
  NCT07404553 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
  NCT07058077 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 43 locations
• A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia
  NCT06568471 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
• A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
  NCT07465263 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia
  NCT07421297 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Alirocumab in Patients on a Stable Dialysis Regimen
  NCT03480568 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
  NCT05621070 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
  NCT05682378 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female) · 52 locations
• Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days
  NCT07614958 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
  NCT06597019 · Phase: Phase 3 · Ages: 6 Years to 11 Years · Sex: All (male and female) · 66 locations
• Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
  NCT06597006 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · 19 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.